Drug & Medication Database
Browse 18,617 FDA-approved medications with detailed information about uses, dosage, side effects, and interactions.
Desmopression Acetate
desmopression acetate
Dosage form: POWDER. Active ingredients: DESMOPRESSIN ACETATE (25 kg/25kg). Category: BULK INGREDIENT.
Desogestrel
desogestrel
Dosage form: POWDER. Active ingredients: DESOGESTREL (1 kg/kg). Category: BULK INGREDIENT.
Desogestrel And Ethinyl Estradiol
desogestrel and ethinyl estradiol
Indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Brands: Desogestrel And Ethinyl Estradiol
Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol
desogestrel and ethinyl estradiol and ethinyl estradiol
DESCRIPTION VIORELE ® (desogestrel and ethinyl estradiol tablets, USP and ethinyl estradiol tablets, USP) provides an oral contraceptive regimen of 21 white to off-white, round tablets each containing 0.15 mg desogestrel, USP (13-ethyl-11- methylene-18,19-dinor-17 alpha-pregn- 4-en- 20-yn-17-ol), 0.02 mg ethinyl estradiol, USP (19-nor-17 alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol), and inactive ingredients which include vitamin E, potato starch, povidone, isopropyl alcohol, colloidal silicon
Brands: Viorele
Desogestrel/ethinyl Estradiol And Ethinyl Estradiol
desogestrel/ethinyl estradiol and ethinyl estradiol
DESCRIPTION Pimtrea TM (Desogestrel and Ethinyl Estradiol tablets, USP and Ethinyl Estradiol tablets, USP) provide an oral contraceptive regimen of 21 dark blue tablets each containing 0.15 mg desogestrel (13-ethyl-11- methylene-18,19-dinor-17 alpha-pregn- 4-en- 20-yn-17-ol), 0.02 mg ethinyl estradiol (19-nor- 17 alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol), and inactive ingredients which include: titanium dioxide, macrogol/PEG 400 NF, hydroxypropylmethylcellulose/hypromellose, FD&C Red No.
Brands: Pimtrea
Desonide
desonide
Desonide lotion is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Brands: Desonide
Desonide 0.05%
desonide 0.05%
DESCRIPTION SECTION description
Brands: Tridesilon Cream
Desonide Micronized
desonide micronized
Dosage form: POWDER. Active ingredients: DESONIDE (100 kg/100kg). Category: BULK INGREDIENT.
Desonide Ointment, 0.05%
desonide ointment, 0.05%
DESCRIPTION Desonide Ointment, 0.05% contains desonide (Pregna-1,4-diene-3,20-dione,11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11ß,16α)) a synthetic corticosteroid for topical dermatologic use. The corticosteroids constitute a class of primary synthetic steroids used topically as anti-inflammatory and antipruritic agents. Chemically, desonide, the active ingredient in Desonide Ointment, 0.05% is C 24 H 32 O 6 .
Brands: Desonide Ointment, 0.05%
Desoximetasone
desoximetasone
Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Brands: Desoximetasone
Desoximetasone Micronized
desoximetasone micronized
Dosage form: POWDER. Active ingredients: DESOXIMETASONE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Desoxycholic Acid
desoxycholic acid
Dosage form: POWDER. Active ingredients: DEOXYCHOLIC ACID (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Desoxycorticosterone Acetate
desoxycorticosterone acetate
Manufactured by NOVARTIS. Dosage form: PELLET. Route: IMPLANTATION. Active ingredients: DESOXYCORTICOSTERONE ACETATE (125MG). Application: NDA005151.
Desoxycorticosterone Pivalate
desoxycorticosterone pivalate
Dosage form: POWDER. Active ingredients: DESOXYCORTICOSTERONE PIVALATE (1 kg/kg). Category: BULK INGREDIENT.
Desoxyribonuclease
desoxyribonuclease
Manufactured by PARKE DAVIS. Dosage form: OINTMENT. Route: TOPICAL. Active ingredients: CHLORAMPHENICOL (10MG/GM); DESOXYRIBONUCLEASE (666 UNITS/GM); FIBRINOLYSIN (1 UNITS/GM). Application: BLA050294.
Desvenlafaxine
desvenlafaxine
Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD).
Brands: Desvenlafaxine
Desvenlafaxine Er
desvenlafaxine er
Desvenlafaxine is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine (O-desmethylvenlafaxine) is the major active metabolite of the antidepressant venlafaxine, a medication used to treat major depressive disorder.
Brands: Desvenlafaxine Er
Desvenlafaxine Fumarate
desvenlafaxine fumarate
Manufactured by TEVA PHARMS USA. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DESVENLAFAXINE FUMARATE (EQ 100MG BASE). Application: NDA205208.
Desvenlafaxine Fumarate Monohydrate
desvenlafaxine fumarate monohydrate
Dosage form: POWDER. Active ingredients: DESVENLAFAXINE FUMARATE MONOHYDRATE (1 kg/kg). Category: BULK INGREDIENT.
Desvenlafaxine Succinate
desvenlafaxine succinate
Desvenlafaxine extended-release tablet is indicated for the treatment of adults with major depressive disorder (MDD).
Brands: Desvenlafaxine Succinate
Desvenlafaxine Succinate Monohydrate
desvenlafaxine succinate monohydrate
Dosage form: POWDER. Active ingredients: DESVENLAFAXINE SUCCINATE (1 kg/kg). Category: BULK INGREDIENT.
Detomidine Hydrochloride
detomidine hydrochloride
Dosage form: POWDER. Active ingredients: DETOMIDINE HYDROCHLORIDE (1 g/g). Category: BULK INGREDIENT.
Detoxifying
detoxifying
Sweep Helps in the detoxification of the body
Brands: Sweep
Deucravacitinib
deucravacitinib
11 DESCRIPTION Deucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor and is described chemically as: 6-(cyclopropanecarbonylamido)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide. The molecular formula is C 20 H 19 D 3 N 8 O 3 and the molecular weight of the free base is 425.47. Deucravacitinib has the structural formula: Deucravacitinib is a white to yellow powder. The solubility of deucravacitinib is pH dependent.
Brands: Sotyktu
Deucravacitinib Premix
deucravacitinib premix
Dosage form: POWDER. Active ingredients: DEUCRAVACITINIB (1 kg/kg). Category: BULK INGREDIENT.
Deuruxolitinib Phosphate
deuruxolitinib phosphate
11 DESCRIPTION LEQSELVI (deuruxolitinib) tablets contain the phosphate salt of deuruxolitinib, a Janus kinase (JAK) inhibitor, for oral administration. Deuruxolitinib phosphate is a white to off-white crystalline solid with the chemical name 1 H -Pyrazole-1-propanenitrile, β-(cyclopentyl-2,2,3,3,4,4,5,5- d 8 )-4-(7 H -pyrrolo[2,3- d ]pyrimidin-4-yl)-, (β R )-, phosphate (1:1). Deuruxolitinib has high aqueous solubility at low pH.
Brands: Leqselvi
Deutetrabenazine
deutetrabenazine
11 DESCRIPTION AUSTEDO XR extended-release tablets and AUSTEDO tablets are formulated with deutetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor for oral administration. The molecular weight of deutetrabenazine is 323.46; the pKa is 6.31. Deutetrabenazine is a hexahydro-dimethoxybenzoquinolizine derivative and has the following chemical name: ( RR, SS )-1, 3, 4, 6, 7, 11b-hexahydro-9, 10-di(methoxy-d 3 )-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one.
Brands: Austedo, Austedo, Austedo Xr
Deutetrabenazine Micronized
deutetrabenazine micronized
Dosage form: POWDER. Active ingredients: DEUTETRABENAZINE (1 kg/kg). Category: BULK INGREDIENT.
Deutivacaftor Spray Dried Dispersion
deutivacaftor spray dried dispersion
Dosage form: POWDER. Active ingredients: DEUTIVACAFTOR (.8 kg/kg). Category: DRUG FOR FURTHER PROCESSING.
Device - Hand-held Rubber Bulb Nebulizer
device - hand-held rubber bulb nebulizer
Please consult the purpose section of the OTC bronchodilator drug label approved for use with this device.
Brands: Device - Nebuclear Md Hand-held Rubber Bulb Nebulizer
Medical Disclaimer
This drug database is for informational purposes only. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.